Screening for Intracranial Aneurysm in Patients with Coarctation: Is It Cost-Effective?

Patients with a history of coarctation of the aorta have a higher prevalence of intracranial aneurysm and frequently suffer subarachnoid hemorrhage at younger ages than the general population.

Buscar aneurismas cerebrales en pacientes con coartación ¿Es costo/efectivo?

The American Heart Association (AHA) and American College of Cardiology (ACC) guidelines recommend intracranial aneurysm screening, but appropriate age and interval of screening remain an uncertainty.

The primary endpoint was to determine the best cost-effectiveness ratio, while secondary endpoints included the incidence of aneurysms with prophylactic treatment and prevented deaths that would have been caused by subarachnoid hemorrhage.

In a simulated cohort of 10,000 patients, researchers estimated a 10.1% lifetime cumulative risk of subarachnoid hemorrhage, which would cause 183 deaths.

A systematic resonance angiography screening at ages 10, 20, and 30 would result in prophylactic treatment for 978 unruptured aneurysms, 19 procedure-related deaths, and 65 subarachnoid-hemorrhage-related deaths.


Read also: FREEDOM with FFR: Different Outcomes?


Adding a screening stage at age 30—instead of just at ages 10 and 20—is cost-effective. Known data about the prognosis of a scheduled aneurysm embolization, when compared to the uncertainty of life quality after a subarachnoid hemorrhage, tilt the scales in favor of adopting a systematic screening approach as the best option.

Conclusion

This probabilistic model supports the AHA/ACC guidelines regarding systematic resonance angiography screening in patients with coarctation of the aorta.

Screening at ages 10, 20, and 30 is cost-effective and increases life expectancy.

Original Title: Screening for Intracranial Aneurysms in Coarctation of the Aorta. A Decision and Cost-Effectiveness Analysis.

Reference: Sarah S. Pickard et al. Circ Cardiovasc Qual Outcomes. 2020;13:e006406. DOI: 10.1161/CIRCOUTCOMES.119.006406.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...